AT361476B - Verfahren zur herstellung von neuen amino- propanolderivaten und deren salzen - Google Patents

Verfahren zur herstellung von neuen amino- propanolderivaten und deren salzen

Info

Publication number
AT361476B
AT361476B AT808277A AT808277A AT361476B AT 361476 B AT361476 B AT 361476B AT 808277 A AT808277 A AT 808277A AT 808277 A AT808277 A AT 808277A AT 361476 B AT361476 B AT 361476B
Authority
AT
Austria
Prior art keywords
salts
producing new
new amino
propanol derivatives
amino propanol
Prior art date
Application number
AT808277A
Other languages
English (en)
Other versions
ATA808277A (de
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762651574 external-priority patent/DE2651574A1/de
Priority claimed from DE19772737630 external-priority patent/DE2737630A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Priority to AT650079A priority Critical patent/AT362374B/de
Priority to AT649879A priority patent/AT361479B/de
Priority to AT649979A priority patent/AT362373B/de
Publication of ATA808277A publication Critical patent/ATA808277A/de
Application granted granted Critical
Publication of AT361476B publication Critical patent/AT361476B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT808277A 1976-11-12 1977-11-11 Verfahren zur herstellung von neuen amino- propanolderivaten und deren salzen AT361476B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT650079A AT362374B (de) 1977-08-20 1979-10-04 Verfahren zur herstellung von neuen amino- propanolderivaten und deren salzen
AT649879A AT361479B (de) 1976-11-12 1979-10-04 Verfahren zur herstellung von neuen aminopro- panolderivaten und deren salzen
AT649979A AT362373B (de) 1977-08-20 1979-10-04 Verfahren zur herstellung von neuen amino- propanolderivaten und deren salzen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762651574 DE2651574A1 (de) 1976-11-12 1976-11-12 Ein neues aminopropanol-derivat und verfahren zu dessen herstellung
DE19772737630 DE2737630A1 (de) 1977-08-20 1977-08-20 Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ATA808277A ATA808277A (de) 1980-08-15
AT361476B true AT361476B (de) 1981-03-10

Family

ID=25771134

Family Applications (1)

Application Number Title Priority Date Filing Date
AT808277A AT361476B (de) 1976-11-12 1977-11-11 Verfahren zur herstellung von neuen amino- propanolderivaten und deren salzen

Country Status (23)

Country Link
US (1) US4146630A (de)
JP (1) JPS5363385A (de)
AR (3) AR218643A1 (de)
AT (1) AT361476B (de)
AU (1) AU510284B2 (de)
CA (1) CA1086740A (de)
CH (3) CH636099A5 (de)
CS (1) CS228106B2 (de)
DD (1) DD133801A5 (de)
DK (1) DK500677A (de)
ES (2) ES472747A1 (de)
FI (1) FI62077C (de)
FR (1) FR2370744A1 (de)
GB (1) GB1541547A (de)
HU (1) HU177410B (de)
IL (1) IL53323A (de)
IT (1) IT1087490B (de)
LU (1) LU78498A1 (de)
NL (1) NL7712220A (de)
PL (2) PL110782B1 (de)
SE (1) SE7712720L (de)
SU (2) SU890975A3 (de)
YU (3) YU266477A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
US4495352A (en) * 1979-02-13 1985-01-22 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
DE2905876A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2922084A1 (de) * 1979-05-31 1980-12-11 Boehringer Mannheim Gmbh Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
AU575153B2 (en) * 1984-04-09 1988-07-21 Du Pont Merck Pharmaceutical Company, The Pharmaceutical compositions and method for treatment for prophylaxis of cardiac disorders
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5789402A (en) * 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
US5741789A (en) * 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
WO2010059393A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Serotonin receptor modulators
US8575364B2 (en) 2008-10-30 2013-11-05 Janssen Pharmaceutica Nv Modulators of serotonin receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB925429A (en) * 1960-04-01 1963-05-08 Irwin Neisler & Co Indole derivatives
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
BE794333A (fr) * 1972-01-20 1973-07-19 Wyeth John & Brother Ltd Composes heterocycliques azotes therapeutiques
JPS48103590A (de) * 1972-04-13 1973-12-25
JPS6024100B2 (ja) * 1975-02-11 1985-06-11 ベーリンガー・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング アミノプロパノ−ル−誘導体の製法
DE2549568C3 (de) * 1975-11-05 1981-10-29 Bayer Ag, 5090 Leverkusen 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Also Published As

Publication number Publication date
JPS5363385A (en) 1978-06-06
FR2370744B1 (de) 1981-06-12
FI62077C (fi) 1982-11-10
LU78498A1 (de) 1979-02-02
ATA808277A (de) 1980-08-15
AR221868A1 (es) 1981-03-31
FI773346A (fi) 1978-05-13
YU266477A (en) 1984-02-29
IL53323A0 (en) 1978-01-31
CA1086740A (en) 1980-09-30
YU128983A (en) 1984-04-30
AR218643A1 (es) 1980-06-30
PL110782B1 (en) 1980-07-31
CH639086A5 (de) 1983-10-31
YU128883A (en) 1984-04-30
AU3046677A (en) 1979-05-17
IT1087490B (it) 1985-06-04
AU510284B2 (en) 1980-06-19
GB1541547A (en) 1979-03-07
SU826955A3 (ru) 1981-04-30
IL53323A (en) 1981-12-31
SU890975A3 (ru) 1981-12-15
FI62077B (fi) 1982-07-30
ES472746A1 (es) 1979-02-16
DD133801A5 (de) 1979-01-24
JPS6341910B2 (de) 1988-08-19
HU177410B (en) 1981-10-28
CH636099A5 (de) 1983-05-13
CS228106B2 (en) 1984-05-14
PL112683B1 (en) 1980-10-31
ES472747A1 (es) 1979-02-16
SE7712720L (sv) 1978-05-13
NL7712220A (nl) 1978-05-17
DK500677A (da) 1978-05-13
CH643554A5 (de) 1984-06-15
PL201997A1 (pl) 1979-03-12
US4146630A (en) 1979-03-27
FR2370744A1 (fr) 1978-06-09
AR221081A1 (es) 1980-12-30

Similar Documents

Publication Publication Date Title
AT374191B (de) Verfahren zur herstellung von neuen substituierten acethydroxamsaeuren und deren salzen
AT363080B (de) Verfahren zur herstellung von neuen heterocyclischen 1-aryloxy-2-hydroxy-3-alkylenaminopropanen und von deren salzen
AT363090B (de) Verfahren zur herstellung von neuen piperazinderivaten und deren salzen
AT348125B (de) Verfahren zur herstellung von neuen aminoglycosidderivaten und deren salzen
AT361476B (de) Verfahren zur herstellung von neuen amino- propanolderivaten und deren salzen
AT365166B (de) Verfahren zur herstellung von neuen peptidderivaten und deren salzen
AT347952B (de) Verfahren zur herstellung von neuen 1,1,1- triarylalkylaminen und deren salzen
AT353970B (de) Verfahren zur herstellung von neuen 7-methoxy- cephalosporinen und deren salzen
ATA262677A (de) Verfahren zur herstellung von neuen 7-amino- alkyl-thiophyllinen und deren salzen
ATA134777A (de) Verfahren zur herstellung von neuen substituierten 2-aminopurinen und deren salzen
AT358020B (de) Verfahren zur herstellung von neuen veresterten aminoalkoholen und deren salzen
AT350584B (de) Verfahren zur herstellung von neuen benzyliden- aminoguanidinen und deren salzen
AT359507B (de) Verfahren zur herstellung von neuen piperazin- derivaten und deren salzen
AT352724B (de) Verfahren zur herstellung von neuen substi- tuierten sulfoximiden und deren salzen
AT358588B (de) Verfahren zur herstellung von neuen 1,2,3,4- -tetrahydroisochinolinen und deren salzen
AT366057B (de) Verfahren zur herstellung von neuen peptidderivaten und deren salzen
AT352727B (de) Verfahren zur herstellung von neuen indol- derivaten und deren salzen
AT362373B (de) Verfahren zur herstellung von neuen amino- propanolderivaten und deren salzen
ATA650079A (de) Verfahren zur herstellung von neuen amino- propanolderivaten und deren salzen
ATA649879A (de) Verfahren zur herstellung von neuen aminopro- panolderivaten und deren salzen
ATA628879A (de) Verfahren zur herstellung von neuen aminoalkoho- len und deren salzen
ATA745579A (de) Verfahren zur herstellung von neuen substituiertenhydantoinen und von deren salzen
AT367750B (de) Verfahren zur herstellung von neuen n2-arylsulfonyl-l-argininamiden und deren salzen
ATA712579A (de) Verfahren zur herstellung von neuen piperazin- derivaten und deren salzen
ATA712479A (de) Verfahren zur herstellung von neuen piperazin- derivaten und deren salzen